As populations age, the threat of osteoporosis and osteoarthritis is looming large in the global consciousness. But bone and joint health go beyond the elderly, with implications for the young, athletes, and beyond.
Natural products with potential bone and joint health benefits - calcium, vitamins D and K, glucosamine, and chondroitin, to name but a few - are big business: The US bone and joint health market was estimated to be worth $178 million in 2008, and is predicted to be $246 million by 2015, according to Frost & Sullivan.
However, conflicting science and regulatory pressures are undermining the potential growth of this market.
The Bone & Joint Health 2011 Virtual Conference will look at what products are working and with whom, how to strengthen the science, and how to formulate a winning product.